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Abstract. Carotid body glomus cells release transmitters in response to hypoxia due to the
increase of excitability resulting from inhibition of O2-regulated K+ channels. The mech-
anisms involved in the detection of changes of O2 tension are unknown. Inhibition of the
mitochondrial electron transport chain (ETC) at proximal and distal complexes induces
external Ca2+-dependent catecholamine secretion. At saturating concentration of the ETC
inhibitors, the cellular response to hypoxia is maintained. However, rotenone, a complex
I blocker, selectively occludes the responsiveness to hypoxia of glomus cells in a dose-
dependent manner. The effect of rotenone is not mimicked by complex I inhibitors acting
on different sites. We have also generated a knock-out mouse lacking SDHD, the small
membrane-anchoring protein of the succinate dehydrogenase (complex II) of the 
mitochondrial electron transport chain. Homozygous Sdhd -/- animals die at early 
embryonic stages. Heterozygous Sdhd +/- mice show a general, non-compensated, defi-
ciency of complex II activity, and abnormal enhancement of resting carotid body secre-
tion rate due to decrease of K+ conductance and persistent Ca2+ influx into glomus cells.
However, responsiveness to hypoxia of carotid bodies from Sdhd +/- mice remains intact.
These data strongly suggest that sensitivity to hypoxia of carotid body glomus cells is not
linked in a simple way to mitochondrial electron flow. Nevertheless, it is possible that a
rotenone-sensitive molecule critically participates in acute carotid body oxygen sensing.
2005 Signalling pathways in acute oxygen sensing. Wiley, Chichester (Novartis Foundation Symposium
272) p 54–72
The carotid body (CB) is a major arterial chemoreceptor that senses blood O2 to
evoke hyperventilation and sympathetic activation in response to hypoxemia (for a
review see López-Barneo et al 2001). The O2-sensing elements in the CB are 
neurosecretory glomus, or type I, cells, which are organized in innervated clusters
in close contact with blood vessels. Glomus cells are electrically excitable and have
several types of O2-sensitive K+ channels in their membranes (López-Barneo et al
1988, Delpiano & Hescheler 1989, Peers 1990, Stea & Nurse 1991, Buckler 1997).
Although the O2-sensitive K+ channel type can change in the different animal
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species, it is broadly accepted that inhibition of the membrane K+ conductance by
low O2 tension (pO2) is the critical event leading to depolarization, external Ca2+
influx and activation of neurotransmitter release, which, in turn, stimulates the
afferent sensory fibres. This ‘membrane model’ of chemotransduction, suggested
by the electrophysiological experiments, has been confirmed by monitoring cytoso-
lic [Ca2+] and quantal catecholamine secretion in single dye-loaded cells (López-
Barneo et al 1993, Buckler & Vaughan-Jones 1994, Ureña et al 1994, Montoro et al
1996, Carpenter et al 2000, Pardal et al 2000).
Despite the progress in glomus cell physiology the nature of the mechanisms
coupling changes of pO2 to K+ channel activity remain unknown. CB research is
hampered by the small size of the organ and the difficulty to obtain a preparation
with reproducible sensitivity to hypoxia, since this is a property easily lost by the
cells. Because modulation of some K+ channels by pO2 is seen in excised patches
(Ganfornina & López-Barneo 1991, Riesco-Fagundo et al 2001) it was postulated
that O2 sensing in glomus cells depends on membrane-delimited mechanisms. In
fact, membrane bound haeme oxygenase 2 has recently been suggested to mediate
O2 sensitivity of heterologously expressed and glomus cell maxi-K+ channels
(Williams et al 2004). On the other hand, several investigators have traditionally con-
sidered mitochondria as the major players in CB O2 sensing because, similarly to
hypoxia, inhibitors of the electron transport chain (ETC) or mitochondrial uncou-
plers increase the afferent activity of the sinus nerve (see, for instance, Mills & Jöbsis
1972). It has also been reported that cyanide and anoxia release Ca2+ from mito-
chondria in isolated rabbit glomus cells (Biscoe & Duchen 1990, Duchen & Biscoe
1992). Although the ‘membrane model’ of CB chemostransduction is unques-
tioned, the interest on mitochondria has resurged in recent years since mitochon-
drial uncouplers raise cytosolic Ca2+ and reduce background K+ permeability in 
rat CB cells (Buckler & Vaughan-Jones 1998). In addition, mutations in the small
membrane-anchoring protein of succinate dehydrogenase (SDHD) in mitochondr-
ial complex II are the main cause of familiar hereditary paraganglioma (PGL) a
mostly benign, highly vascularized tumour of the CB (Baysal et al 2000). Similar to
CB of individuals exposed chronically to hypoxia, PGL tumours display cellular
hyperplasia/anaplasia. Moreover, the prevalence of PGL in individuals with SDHD
mutations increases in high-altitude living populations (Astrom et al 2003). Thus, it
has been proposed that SDHD participates in O2 sensing and that PGL tumours
are induced by defects in the detection of blood O2 levels (Baysal et al 2000,
Gimenez-Roqueplo et al 2001). It is, therefore, plausible that mitochondria are the
site for glomus cell O2 sensing and that in response to hypoxia they signal the mem-
brane to modulate K+ channel activity.
Herein, we summarize recent work in our laboratory designed to investigate
whether sensitivity of intact glomus cells to hypoxia is altered by mitochondrial 
dysfunction induced either pharmacologically (Ortega-Sáenz et al 2003) or by 
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deletion of the SDHD gene (Piruat et al 2004). We describe the effect of mito-
chondrial ETC inhibition on glomus cell K+ conductances and responsiveness 
to low pO2 as well as the physiological features of CB glomus cells from Sdhd
knockout mice.
Experimental procedures
Most of the experiments were performed using the carotid body thin slice prepa-
ration in which the response of glomus cells to low pO2 can be studied in almost
optimal physiological conditions (Pardal et al 2000, Pardal & López-Barneo 2002).
Amperometric recordings of catecholamine released from rat or mouse CB slices
as well as patch clamp studies on isolated glomus cells were carried out following
the procedures previously described (Ortega-Sáenz et al 2003, Piruat et al 2004).
Changes in the solution composition or experimental conditions not previously
published are indicated in the figure legends. Generation and genetic characteriza-
tion of the Sdhd knockout mice are described in Piruat et al (2004).
Results and discussion
Glomus cell sensitivity to hypoxia and pharmacological ETC inhibition
In rat CB slices hypoxia (switching from a solution with a pO2 of 150 mmHg to
another with ª15 mmHg) induced catecholamine release in an external Ca2+-
dependent manner (Fig. 1A). Similar to hypoxia, exposure of glomus cells to ETC
inhibitors also produced an external Ca2+-dependent secretory response. The effect
is shown for rotenone and cyanide (inhibitors of complex I and IV, respectively) in
Fig. 1B & C, but it was also observed with blockers of complex II (thenoyltrifluo-
roacetone; TTFA) and III (myxothiazol and antimycin A) (Ortega-Sáenz et al 2003).
The interaction between hypoxia and the mitochondrial electron flow was studied
in cells exposed to low pO2 before and during application of ETC inhibitors. The
rationale behind these experiments was that if hypoxia exerts its effect through
alteration of the mitochondrial electron flow, preincubation with saturating con-
centrations of ETC blockers would prevent any further effect of low pO2. In con-
trast, the effects of hypoxia and ETC inhibition would be additive, at least partially,
if they were acting through separate pathways. With the exception of rotenone, that
occluded sensitivity to hypoxia (Fig. 1E), the ETC tested evoked secretory responses
that were additive with that elicited by hypoxia (Fig. 1D–F). The differential effect
of rotenone is particularly evident when the cumulative secretion signals recorded
during concomitant exposure to the ETC inhibitors and hypoxia are shown at an
expanded time base (right panels in Fig. 1 D & E). The effect of rotenone was
observed in all the cells studied (n = 28) with concentrations of the drug between
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FIG. 1. Secretory responses of glomus cells to hypoxia and to the inhibition of the mitochon-
drial electron transport. (A–C) Amperometric signals showing catecholamine release from a
glomus cell exposed to either hypoxia (ª 20 mmHg) or to electron transport inhibitors (5 mM
rotenone and 100 mM cyanide). Each spike represents an exocytotic event. In all cases secretion
is reversibly abolished by external application of 0.3 mM cadmium. (D, E) Secretory responses
of glomus cells exposed concomitantly to hypoxia (pO2 ª 20 mmHg) and to cyanide (100 mM) or
rotenone (5 mM). Left panels in D & E are the amperometric recordings, right panels are the
cumulative secretion signals (in femtocoulombs) before, during, and after the exposure to hypoxia
in the presence of the ETC inhibitors. The exposures to hypoxia are marked with an asterisk in
the left panels. The straight lines represent the slopes (secretion rates) of the cumulative secre-
tion signals immediately before the exposure to hypoxia. (F) Average secretion rate (ordinate in
femtocoulombs/min, mean ± SE) measured in cells in various experimental conditions. From left
to right: Control (pO2 ª 150 mmHg, n = 17 cells) and hypoxia (pO2 ª 20 mmHg, n = 17 cells).
Cyanide and cyanide plus hypoxia (100 mM, n = 4 cells). Antimycin A (0.1 to 1 mg/ml, n = 13 cells)
and antimycin A plus hypoxia (n = 7 cells). Myxothiazol (0.1 to 1 mg/ml, n = 6 cells) and myxoth-
iazol plus hypoxia (n = 6 cells). TTFA (0.1 to 0.3 mM, n = 5 cells) and TTFA plus hypoxia (n = 5
cells). Rotenone (0.1 to 5 mM, n = 14 cells), rotenone plus hypoxia (n = 12 cells). Asterisks indi-
cate statistically significant difference (P < 0.05) between each pair of samples.
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0.1 and 5 mM and was mimicked by 1-methyl-4-phenylpyridinium ion (MPP+)
(which binds to the same site as rotenone) but not by other drugs (as rhein or dio-
phenyleneiodonium) acting on different sites in mitochondrial complex I (Ortega-
Sáenz et al 2003). These data suggested that ETC inhibition and hypoxia might act
through separate signalling pathways. However, rotenone, at concentrations that
fully block complex I (Degli Esposti 1998, Vaux et al 2001) or saturate rotenone
binding sites (Higgins & Greenamyre 1996) selectively occludes responsiveness to
hypoxia in CB cells. Therefore, it seems that a rotenone (and MPP+)-inhibitable
molecule participates critically in CB O2 sensing.
To further investigate the effect of ETC inhibitors on glomus cells, we recorded
ionic currents from patch clamped cells using the perforated patch-clamp technique.
Although the action of the ETC inhibitors tested in this set of experiments was
rather variable, their most common qualitative effects are summarized on Fig. 2.
Rotenone, antimycin A and cyanide all produced a marked reduction in the ampli-
tude of the K+ currents that, particularly in the case of antimycin A, was frequently
irreversible (Fig. 2A). Application of depolarizing ramps demonstrated that besides
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FIG. 2. Electrophysiological effects of mitochondrial inhibitors on dispersed rat glomus cells.
(A) Macroscopic K+ currents recorded from perforated patch clamped cells subjected to step
depolarization to the indicated membrane potentials (holding potential, -80 mV). Control and
recovery traces are in black. Traces recorded in the presence of antimycin A (1 mg/ml), rotenone
(3 mM) or cyanide (100 mM) are in grey. (B, C) Currents recorded during the application of depo-
larizing voltage ramps in perforated patch clamped glomus cells. Experimental conditions as 
in A.
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the effects on voltage-dependent outward current amplitude, rotenone and cyanide
also reduced membrane resting conductance and displaced to more positive poten-
tials the zero current level (Fig. 2B & C). These observations suggested that,
as indicated by Wyatt & Buckler (2004), the two agents decrease background K+
conductance. In contrast, antimycin A (1 mg/ml) had no affect on the resting con-
ductance of glomus cells (Fig. 2C). Hence, antimycin A and cyanide, which have
similar effects on secretion, have different actions on the resting K+ conductance.
Rotenone and cyanide, with almost identical electrophysiological effects influenced
in different ways the O2 sensitivity of the glomus cells. These data suggest that
glomus cell secretion induced by the ETC inhibitors is probably the result of the
pharmacological effect of these drugs on K+ channels, unrelated to their effect on
the mitochondrial electron transport. In fact, rotenone reversibly inhibits the
macroscopic K+ currents in cells devoid of mitochondria (Searle et al 2002).
Persistent carotid body activation with normal glomus cell responsiveness to hypoxia in 
partially Sdhd-deficient mice
To evaluate the participation of mitochondrial complex II in CB O2 sensing, we
have generated a mouse model lacking SDHD, a component of succinate dehy-
drogenase (Piruat et al 2004). SDHD deficiency is the most frequent manifestation
of the hereditary paraganglioma (PGL, Baysal 2003), a catecholamine-secreting
tumour in the neck affecting the carotid body (CB). PGL tumours display cellular
hyperplasia/anaplasia similar to the CB of individuals exposed to chronic hypoxia
(Lahiri et al 2000, Wang & Bisgard 2002), thus it has been proposed that the ulti-
mate cause of PGL tumours is a defect in sensing environmental O2 levels (Baysal
et al 2000, Gimenez-Roqueplo et al 2001, Rustin et al 2002, Baysal 2003). We have
tested in young adult mice whether partial Sdhd deficit and inhibition of mitochon-
drial complex II activity alter CB function by monitoring single-cell secretory 
activity in slices of the whole organ. Similar to rat CB slices (Pardal et al 2000,
Ortega-Sáenz et al 2003), the response to hypoxia of glomus cells in mouse CB
slices was characterized by a sharp and reversible burst of secretory events (Fig.
3A). This response was maintained, or even augmented, in Sdhd +/- mice (Fig. 3B–C),
indicating that partial deficiency of complex II activity does not seem to alter
glomus cell responsiveness to hypoxia. However, spontaneous CB activity in nor-
moxic conditions was increased by ~2.4-fold (statistical significance, P < 0.05) in
Sdhd +/- animals as compared with wild-type littermates (Fig. 3D). The higher resting
excitability of CB cells in Sdhd +/- animals also explained the slight increase of the
hypoxic response. The spontaneous secretory activity of Sdhd +/- glomus cells was
reversibly abolished by blockade of Ca2+ channels with Cd2+ (Fig. 3E), thus sug-
gesting that it was due to persistent extracellular Ca2+ influx through membrane
channels (Pardal et al 2000, Ortega-Sáenz et al 2003).
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FIG. 3. Secretory activity and responsiveness to hypoxia of carotid body glomus cells. (A, B)
Secretory response to hypoxia of glomus cells of Sdhd +/+ and Sdhd +/- mice. Cumulative secretion
(in fC) for each experiment are shown. (C) Quantification of the secretory response to low O2
tension (in fC/last min hypoxia) of SDHD deficient (mean ± SE, n = 16) and wild-type (n = 18)
mice. Anova test, P = 0.12. (D) Quantification of the spontaneous secretory activity in a carotid
body slice from Sdhd +/+ (mean ± SE, n = 16) and wild-type (n = 18) mice. Kruskal-Wallis test,
P = 0.01. (E) Spontaneous secretory activity in a Sdhd +/- glomus cell and reversible blockade 
by application of 0.3 mM extracellular cadmium.
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The constitutive functional activation of CB glomus cells observed in Sdhd-
deficient mice occurred with only minor morphological changes in CB structure,
without obvious organ enlargement or gross histological modifications. We have
only observed a slight, although significant, increase in the percentage of glomus
cells, identified by their immunoreactivity to tyrosine hydroxylase (TH), the rate-
limiting enzyme for catecholamine synthesis (Piruat et al 2004). These subtle glomus
cell hyperplasia probably precede CB tumour transformation. In humans, loss of
heterozygosity (LOH) of the wild-type allele is required for PGL to occur (Baysal
et al 2000, Baysal 2003). The absence of tumours in the Sdhd +/- mice suggests that
the induction of LOH in CB glomus cells depends on different factors in humans
and rodents.
Decrease of glomus cell K + current density in Sdhd +/- mice
We have studied the K+ currents in voltage clamped glomus cells, as it is known
that in this preparation K+ channels regulate membrane potential and cellular
excitability (see Pardal et al 2000 and references therein). Representative families of
K+ currents recorded from Sdhd +/+ and Sdhd +/- glomus cells using the perforated
patch clamp technique are illustrated in Fig. 4A, B. The average K+ current density-
voltage relationships are shown in Fig. 4C. Although other changes in the K+ cur-
rents have been reported before (see Piruat et al 2004), the most obvious and
consistent modification induced by partial deletion of the Sdhd gene was a reduc-
tion in total K+ current density from 4.6 ± 1.5 pA/mm2, n = 6 in Sdhd +/+ to 2.5 ±
0.8 pA/mm2, n = 6 for Sdhd +/-, at +20 mV. It is known that Ca2+-activated K+ chan-
nels contribute to the macroscopic voltage-dependent K+ current and the resting
potential of rodent glomus cells (Wyatt & Peers 1995, Pardal et al 2000), and that
in most tissues these channels act as counter-regulatory devices that prevent exces-
sive cell depolarization. Therefore, the biophysical changes observed in patch
clamped Sdhd +/- glomus cells could account for the persistent secretory activity
detected in intact cells by amperometry.
Conclusions
Our data indicate that, as hypoxia, ETC inhibitors induce a secretory response in
carotid body glomus cells, which is dependent on extracellular Ca2+. They also
suggest that sensitivity to hypoxia of carotid body glomus cells is not linked in a
simple way to mitochondrial electron flow. In fact, all the ETC inhibitors tested
have a non-specific pharmacological action as blockers of voltage-gated K+ chan-
nels. However, a rotenone (and MPP+)-sensitive molecule, located either inside or
outside mitochondria, appears to participate in acute oxygen sensing in the carotid
body. Partial genetic deficiency of mitochondrial complex II due to Sdhd deletion
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produces persistent carotid body glomus cell activation and a decrease of K+
channel current density. Sensitivity to hypoxia of these cells was, however,
unaltered.
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DISCUSSION
Weir: What temperature were your experiments done at, and does it matter
whether you do them at room temperature?
López-Barneo: All the experiments on carotid body slices are done at between 34
and 36 °C. The experiments in dispersed cells were done at room temperature. At
room temperature the slices also respond to hypoxia, but the effect is slower and
less potent.
Weir: Was the membrane potential depolarised with any of the mitochondrial
inhibitors?
López-Barneo: I can’t remember. But I suspect that those decreasing K+ conduc-
tance would depolarise the membranes. I am not sure about antimycin A. We haven’t
measured directly the membrane potential in response to metabolic activity.
Weir: Is the additional rotenone effect in ablating the hypoxic effect related to its
ability to cause depolarization?
López-Barneo: I can’t answer that, since we have not performed this type of
experiment.
Buckler: Your ion channel experiments were all in perforated patch. So how 
do you know that the effects of rotenone or antimycin on your channels are non-
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selective and non-specific, as opposed to being mediated via an effect upon on the
mitochondria?
López-Barneo: We did whole-cell recording in perforated patches and measured
the K+ currents. Antimycin A, rotenone and cyanide all produce, in addition, to
mitochondrial inhibition blockade of K+ channels. We don’t see any major differ-
ence between them. However, when we do the experiment using the same con-
centration in the slices we see a differential effect with each. All three activate the
carotid body, but only rotenone will block the sensitivity to hypoxia. The way we
interpret this is that what we are seeing in the whole cell recording is a pharmaco-
logical action. I am concerned about the use of these drugs without testing what
else they do. When you say a molecule is a mitochondrial inhibitor, it can do many
other things. One thing that interests us is the differential effect of antimycin A,
rotenone and cyanide.
Buckler: Did you do a dose–response for antimycin A or cyanide with respect to
the hypoxia effect? With rotenone, whether you got additivity (with hypoxia) or not
depended on the concentration of rotenone you used. Did you do the same for
cyanide or antimycin A? If you push the concentration of antimycin or cyanide up
higher can you saturate the response?
López-Barneo: We haven’t done this. In our hands, if we go to high concentrations
of cyanide we see a response due to release of calcium from internal stores and
therefore you can’t do the experiment. With antimycin A, the concentration we are
using is already non-reversible.
Buckler: Just because you get Ca2+ release from internal stores doesn’t mean that
you can’t do the experiment. You are looking for additivity between hypoxia and
metabolic inhibitors.
López-Barneo: In our hands, if we go to higher concentrations of cyanide we get
Ca2+ release from the stores, massive secretion and irreversible damage to the cells.
Buckler: If you say that a higher concentration of antimycin is toxic, then this
suggests to me that the concentration of antimycin you are using routinely is not
toxic because it is probably insufficient to fully inhibit mitochondrial function.
So how then can you take additivity between a sub maximal level of antimycin 
and hypoxia as evidence that hypoxia acts via a pathway independent of the 
mitochondrion?
López-Barneo: The assumption I made is that the drugs are used at saturating 
concentrations for electron chain inhibition. The doses we are using are at least five
times higher than others have reported will inhibit the electron transport chain.
Murphy: I know nothing about carotid bodies, but the parallel between glucose-
stimulated insulin release in pancreatic b cells and the response of the carotid body
to hypoxia must be one that is familiar to you. In b cells mitochondrial function
affects the ATP/ADP ratio and thereby alters the K+ channel and consequently
activates the Ca2+ channel. In the carotid body an effect of oxygen on the
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ATP/ADP ratio could also act on the K+ channel in a similar way. The critical thing
is that the ATP/ADP ratio is the link, a mitochondrial way of signalling through a
K+ channel and then to a Ca2+ channel. If you could measure the ATP/ADP ratio
in these cells during hypoxia that might be quite informative. This is easy to do even
in very small numbers of cells because the assay is very sensitive. With respect to
mitochondrial respiratory chain inhibitors, there is considerable evidence that many
of these have secondary effects, in addition to inhibition of respiration: usually at
concentrations considerably above the effect of the inhibitors on respiration. It
seems important to me to first show that you have added just enough inhibitor to
completely inhibit respiration and then determine whether the inhibitor is having
an effect on the endpoint of interest. Then you can increase the concentration of
the inhibitor to see if the inhibitor has secondary effects in addition to inhibition
of respiration. For example, at low concentrations rotenone is known to inhibit
complex I, but at higher concentrations it is thought to have a secondary effect 
and increase ROS production. Another example is antimycin which inhibits the
cytochrome/Bcl1 complex, but at higher concentrations it also affects Bcl2 family
proteins. To summarize, it seems critical to me to first be certain that the effects of
the inhibitors are due solely to the inhibition of respiration.
López-Barneo: It is difficult to do this.
Murphy: I accept that it is technically tricky to measure respiration in small
amounts of tissue, but you could achieve the same end by measuring a surrogate
of respiration such as the ATP/ADP ratio, or cytochrome reduction levels, which
are far easier to measure on small numbers of cells. Similarly, you also assess the
membrane potential using a fluorescent probe such as JC1.
Buckler: Determining whether electron transport is fully blocked or not is actu-
ally quite easy in isolated cells. You use a fluorescent indicator of mitochondrial
potential, fully depolarize the mitochondria with a suitable uncoupler and then see
whether they can repolarize when you withdraw the uncoupler in the presence of
which ever inhibitor of electron transport you are interested in (see e.g. Wyatt &
Buckler 2004).
López-Barneo: I don’t think you can do a good measurement. We do have a drug
that in addition to inhibiting mitochondrial electron transport will produce block-
ade of the K+ channel. I don’t think you can measure mitochondrial membrane
potential in glomus cells.
Rich: I have a comment concerning the protocol for using these mitochondrial
inhibitors. Do you have a continuous flow of a buffer with the inhibitor in it, in
your experiments?
López-Barneo: Yes.
Rich: In this case it raises a difficult technical question that you have to address.
The majority of these inhibitors, such as rotenone and antimycin A, have partition
coefficients between the aqueous solution and the targeted membranes of 108 or
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more for partitioning into the membrane compared with the liquid. Hence, if you
are doing this addition in a cuvette and add 1 mM rotenone, essentially all of the
inhibitor will go into the membrane and almost none will be left free in solution.
However, if you have a continuous flow, and you are continuously replenishing the
rotenone, the inhibitor will continue to build up in the membranes until its con-
centration becomes astronomical. In fact, you can think of it as replacing a lipid
membrane by a rotenone membrane! Secondary effects are therefore inevitable,
which are not of any physiological relevance.
López-Barneo: That is my point. We are getting a high concentration of the drug.
This is the basis of all our assumptions. But even in this situation there can be
further sensitivity to hypoxia in the case of myxothiazol, antimycin A and cyanide
but not in the case of rotenone.
Rich: Getting back to the technical aspects, you can look in the literature and see
that rotenone has a binding constant of something like 10-9 M for the complex I
site. You might assume that you could add just 10 times that concentration to the
cells and get 90% inhibition, which is true, but only if the inhibitor has unhindered
access it its binding sites. But in practice, if you only add 10 times the Km to cells,
the rotenone firstly encounters the cell membrane and because the partition coef-
ficient is 108 or more towards the membrane, the rate constant of entry into the
membrane is very fast but the rate constant out towards the mitochondrial sites can
be hours. It enters the cell membrane, and you don’t get any inhibition of mito-
chondrial respiration because of difficulty in equilibrating to the mitochondria.
Hence, when you add 10 nM rotenone to cells there is no effect on mitochondrial
respiration even though this concentration is above the binding constant. It is not
because there is a different affinity; it is because of the difficulty of delivering the
drug to the site through the other membranes where it resides for a long time. All
this needs to be taken into account when we are looking at these chemicals with a
complex system such as a whole cell. There are great technical difficulties in titrat-
ing because any inhibition will be extremely time dependent.
López-Barneo: Of course, we care about these technical issues, but in fact the com-
plications are working in our favour in the experiments. For example, relatively large
concentrations of antimycin A put in the bath increases a lot of secretory activity
because it is probably doing bad things to the cell, but it still isn’t reducing sensi-
tivity to hypoxia, whereas rotenone is having an effect.
Rich: But these are all artefactual effects from flooding the membranes with
inhibitor.
López-Barneo: The sensitivity to hypoxia is a very sudden phenomenon in the cell.
It is irreversible with rotenone. With the other drugs hypoxia will increase secre-
tory activity, and when this is removed the effect of hypoxia disappears even when
the drug remains. It could be that rotenone is not binding anywhere, of course.
Hypoxia could be having some non-specific effect on the cell. We saw this a couple
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of years ago and since then we have been trying hard to get rotenone-binding sites
outside mitochondria. It could be that this is a non-specific effect of hypoxia,
though.
Rich: There are hundreds, perhaps thousands, of inhibitors that hit the rotenone
site. It might be worth trying some of these.
López-Barneo: Other blockers of mitochondrial complex I didn’t do this, but
MTPT, which binds to the same site than rotenone on mitochondria, did.
Rich: Those two you mention are complicated ones that are non-specific, but you
might consider some of the ultraspecific tight binding inhibitors. Some of them
have unmeasurably tight binding constants.
Gurney: I have a question concerning the link between the K+ channel, the 
Ca2+ channel and secretion. Do you just see a lack of reproducibility in the 
effect of hypoxia on K+ current in the isolated cells, or is it also variable in 
the slices?
López-Barneo: More in the isolated cells, but it is still there in the slices.
Gurney: That makes me wonder whether K+ channels actually mediate the secre-
tory response, which seems robust. I wonder if the cadmium effect is due to block
of non-selective cation channels rather than voltage-dependent Ca2+ channels. The
ATP effect on the cells could be relevant here: although cytoplasmic ATP seemed
to have a big effect on the Ca2+ current, you indicated that it doesn’t seem to affect
the secretory response. This would also tend to dissociate the Ca2+ channels from
the secretory response. Could it be that voltage-gated Ca2+ channels are not neces-
sarily a mediator?
Lopez-Barneo: We didn’t measure the secretory response related to ATP. We meas-
ured the response to hypoxia in cells dialysed with and without ATP. We looked at
the Ca2+ concentration.
Gurney: This wasn’t affected, which makes me think that the rise in Ca2+ concen-
tration is not due to the L-type Ca2+ channels. Could it be that non-selective cation
channels are responsible?
López-Barneo: We have looked at the effect of hypoxia on cation channels. It
doesn’t affect them. People working on rat carotid body cells have shown that the
macroscopic K+ channels are inhibited by hypoxia or the resting potential back-
ground K+ channels are inhibited by hypoxia, but no one has reported an increase
in the cation conductance in response to hypoxia. We are now seeing that hypo-
glycaemia is producing an increase in this cation conductance.
Gurney: The effects on K+ currents are really quite small. Is this enough to cause
depolarization? They are small at quite positive potentials, so at the resting poten-
tial what would happen?
López-Barneo: This is ongoing question. The resting potential in the perforated
patches is 40–50 mV. When we look carefully at the ramps to see where the voltage-
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gated K channels are activated, we can see that some channels are activated around
-40 mV. If we use TEA in these preparation this will produce depolarisation and
increase secretory activity.
Gurney: Are the ramps you are looking at purely activating K+ current?
López-Barneo: It could also be other cation current. The nature of the channel
that is responsible for the receptor potential for the depolarization in carotid body
cells is a question that has been debated over the last decade. I haven’t been working
on the rabbit carotid body for a decade now, but I find it very different from the
rat carotid body. The rabbit carotid body contains a lot of Na+ channels and carotid
body cells in situ and at the oxygen concentration in the arterial blood probably fire
action potentials repetitively. Voltage-dependent K+ channels are probably more
important in the rabbit than in the rat where resting potential K+ channels are
needed to initiate a depolarizing receptor potential.
Evans: I was wondering about the range of experiments you were presenting. If
we disregard non-selective actions of the various mitochondrial inhibitors that you
have used, you could have a varying degree of inhibition of mitochondrial func-
tion. This could underpin the variable effects on carotid body glomus cells of dif-
ferent mitochondrial inhibitors and the variability seen with respect to their ability
to attenuate or not the response to hypoxia. Where the effect of glucose is con-
cerned, the other issue that I’d like to raise is that rotenone may well block the
response to hypoxia by cutting out the mitochondria. However, this doesn’t neces-
sarily mean that the signal transduction pathway utilized by glucose removal is dif-
ferent form that activated by hypoxia. By blocking the mitochondria you will
increase a cell’s reliance on glycolysis for ATP production. Any effect on cells of
altering the glucose concentration could be mediated by the modulation of a meta-
bolic signalling pathway sensitive, in some way, to changes in ATP supply. Such a
pathway could be regulated by changes in the metabolic status of a cell by changes
in glycolytic and/or mitochondrial ATP supply.
López-Barneo: We know that low glucose in carotid body cells produces an increase
in secretory activity. This is dependent on the rise of internal Ca2+ concentration
due to influx from the outside. In our preliminary voltage clamp experiment we
showed that low glucose also inhibited the macroscopic K+ current. We have found
that in addition to this the more reproducible physiological effect of low glucose is
a depolarizing receptor potential that is due to activation of resting non-selective
cation conductance. This can be seen in the presence of TEA and iberiotoxin. This
conductance is not affected by low pO2. It seems that a major mechanism for sig-
nalling low glucose is this cationic conductance. We know that this isn’t related to
glucose itself, because when glucose is replaced by O-methyl glucose (which is
imported but which isn’t phosphorylated or metabolized), there is no effect. We
don’t know what the signal generated as a consequence of glucose metabolism that
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is modulating the non-selective conductance in glomus cells. We have data showing
that the non-selective cation conductance is activated by low glucose and produces
a depolarization of the carotid body cell.
Gonzalez: Do you think that the difference between rotenone and the other mito-
chondrial inhibitors could be because rotenone inhibits the production of reactive
oxygen species?
López-Barneo: We haven’t looked at this. Although the experiments in which we
load the cells with new internal solutions are very complicated, we could investi-
gate the point you are raising by loading the cells with a large amount of DTT or
another reducing agent. Of course, it could be that reactive oxygen species pro-
duced in mitochondria are signalling the membrane. However, it is interesting that
rotenone is the only mitochondrial complex I inhibitor that in our preparation can
occlude sensitivity to hypoxia. We cannot discard that somehow the mitochondrial
complex I acts as an oxygen sensor. I would expect that both antimycin A and
cyanide would increase the radical production at the rotenone site. However they
behave differently with respect to the background K+ channels (cyanide inhibits
them and antimycin A appears to have no effect).
Gonzalez: I was disappointed to see that the carotid bodies on your knockout mice
were not hypertrophic. This is surprising at the view of your findings the carotid
bodies are permanently activated and that their chemoreceptor cells have perma-
nently high levels of intracellular Ca2+. It is constant activation of chemoreceptors
cells what leads to hypertrophy of the carotid bodies in permanent residents at high
altitude.
López-Barneo: To have a tumour you probably need to lose the normal allele.
We are changing the genetic background of this animal model to see whether in a
different background we can get carotid body tumours.
Archer: This is an elegant mouse model, but the problem with the BL6 back-
ground is that it doesn’t hypertrophy very well. This is a recurring problem with
BL6 backgrounds: they don’t have a robust remodelling response to vascular injury.
If you are failing to see hypertrophy when you are expecting it this might well be
the mouse strain-related phenomenon. Although Paul and I don’t agree on the
effects of hypoxia on pulmonary vascular radical production, we do agree that mito-
chondria are important as sensors. What is surprising is that when you gave a variety
of mitochondrial inhibitors to the carotid body, they caused carotid body discharge,
thereby mimicking what hypoxia does, and one of the inhibitors actually ablated
subsequent hypoxic responses. Wouldn’t the simplest interpretation of these obser-
vations be that mitochondria are important in the carotid body’s hypoxic response?
You attribute the effects to non-specific effects. When you get all those mitochon-
drial inhibitors and they all cause discharge in the carotid body, wouldn’t that point
at the mitochondria? I am surprised that your interpretation was that it was not
mitochondria.
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López-Barneo: I don’t mind interpreting the data a different way, the problem is
that I don’t know how to do it. The way I interpret these data is that it is unlikely
that acute oxygen sensing in the carotid body is associated with mitochondria.
Duchen: With rotenone, one of the things that surprises me is that it doesn’t ablate
the response to hypoxia, it stops it. Your slope was cumulative and secretion was
repressed by rotenone. I don’t understand how this works. If rotenone was doing
what it does, you’d expect it to continue irrespective of whether you apply hypoxia
or not. Why do you get a decrease in secretion? How do you interpret this?
López-Barneo: On average, hypoxia wouldn’t decrease secretory activity in
rotenone. This occasionally happened but not always. When we used large con-
centrations of rotenone (say above 1 mM) the effect of rotenone was rather irre-
versible and after removal of the drug the cells were still insensitive to hypoxia. In
these cases hypoxia did not increase secretory activity of the rotenone-treated cells
but it did not produce inhibition of secretion either.
Duchen: We did the same experiment many years ago, measuring [Ca2+] as an end-
point, and found that all the mitochondrial inhibitors blocked the [Ca2+] response
to hypoxia.
Chandel: Does FCCP do the same thing?
Duchen: Yes.
Chandel: So why not add FCCP first and then use the mitochondrial inhibitors?
This would get rid of the effect the mitochondrial membrane potential might have
on Ca2+.
Lopez-Barneo: The problem with glomus cells is that this would probably kill them.
Gonzalez: If you use uncouplers you would have maximal activation of the cells.
Chandel: But you would still see hypoxic activation on top of this.
Gonzalez: I doubt it, particularly if you use the high concentration of uncouplers
needed to fully abolish the mitochondrial potential.
Buckler: There have been a number of studies looking at chemoreceptor dis-
charge with antimycin and oligomycin. More recently there has been a study looking
at FCCP. (Mulligan et al 1981, Mulligan & Lahiri 1982, Mosqueria & Iturriaga 2002).
They all seem to find occlusion, i.e. there is little or no effect of hypoxia in the pres-
ence of mitochondrial inhibitors.
Duchen: The main difference is the endpoint that is measured.
Schumacker: Your rationale for the SDHD knockout was very clear, but to be fair,
the mechanisms that cause tumour formation in cells and those that regulate the
oxygen sensing capacity might be very different. It would seem that the appropri-
ate controls would be to look at the homozygous SDHA knockout. You ought to
see the same phenotype with the SDHA as with the SDHD if succinate was the
mechanism, or if the mechanism was related to a general slow down of Krebs cycle.
López-Barneo: Has the SDHA knockout been done?
Schumacker: No, but there are ES cells.
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Gonzalez: A quick comment. I think that most familial chemodectomas are pro-
duced by fibroblasts growth in the carotid bifurcation. Very few chemodectomas in
humans are functional, that is, very few chemodectomas are due to proliferation of
chemoreceptor cells.
López-Barneo: This might be true. Nevertheless, it is also well known that para-
gangliomas contain a large number of catecholamine-secreting glomus cells. In fact,
they can produce systemic hypertension.
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